Jiongliang Wang

1 article listing Jiongliang Wang in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study Nature Communications